HCV - Hep C key lies in new needles, not education

Hep C key lies in new needles, not education
Australian, Australia - Feb 19, 2006... About 75 per cent of people infected are likely to progress to chronic hepatitis C, with the virus in the bloodstream for more than six months. ...

XTL Biopharmaceuticals to Present at the JPMorgan Small Cap ...
PR Newswire (press release), NY - Feb 13, 2006... of two monoclonal antibodies against the hepatitis C virus - presently in Phase 1 clinical trials in patients with chronic hepatitis C. XTLbio's hepatitis C ...

Viral Hepatitis and HIV Coinfection
Medscape (subscription) - Feb 3, 2006... After adjusting for chronic hepatitis C, the frequency of isolated anti-HBc did not differ when comparing HIV-infected and HIV-uninfected women. ...

MIGENIX to Participate in "Breakthroughs in Hepatitis" Focus ...
Canada NewsWire (press release), Canada - Feb 13, 2006... and will present MIGENIX's celgosivir (MX-3253), a first-in-class alpha glucosidase 1 inhibitor for the treatment of chronic Hepatitis C infections. ...